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Abstract 
Aims: The aim of this study was to analyze if the pre-administration of 
anthocyanin on memory and anxiety prevented the effects caused by 
intraceberoventicular streptozotocin (icv-STZ) administration-induced sporadic 
dementia of Alzheimer’s type (SDAT) in rats. Moreover, we evaluated whether 
the levels of nitrite/nitrate (NOx), Na+,K+-ATPase, Ca2+-ATPase and 
acethylcholinesterase (AChE) activities in the cerebral cortex (CC) and 
hippocampus (HC) are altered in this experimental SDAT.  
Main methods: Male Wistar rats were divided in 4 different groups: control 
(CTRL), anthocyanin (ANT), streptozotocin (STZ) and streptozotocin+ 
anthocyanin (STZ+ANT). After seven days of treatment with ANT (200 mg/kg; 
oral), the rats were icv-STZ injected (3 mg/kg), and four days later were 
performed the behavior parameters and submitted to euthanasia.  
Key findings: A memory deficit was found in STZ group, but ANT treatment 
showed to prevent this impairment of memory (P<0.05). Our results showed a 
higher anxiety in icv-STZ group, but the treatment with ANT showed a per se 
effect and prevented the anxiogenic behavior induced by STZ. Our results 
reveal that ANT (100µM) tested diplace the specific binding of [H3] 
flunitrazepam to benzodiazepinic site of GABAA receptors. AChE, Ca
+-ATPase 
activities and NOx levels were found to be increased in HC and CC in STZ 
group, which was attenuated by ANT (P<0.05). STZ decreased Na+,K+-ATPase 
activity and ANT was able to prevent these effects (P<0.05).  
Significance: In conclusion, these findings demonstrated that ANT is able to 
regulate ions pump activity and cholinergic neurotransmission, as well as able 
to enhance memory and act as anxiolytic compound in animals with SDAT. 
Keywords: Anxiety-like behavior; Nitric oxide production, Acetylcholinesterase, 
Anthocyanin; ICV-streptozotocin; Memory; Rats 
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1. Introduction  
Anthocyanins (ANT) belong to the flavonoid family, which present 
phenolic groups in their chemical structure and give colors to a great variety of 
flowers and fruits (Table1) (Veitch and Grayer, 2011, Williams and Grayer, 
2004, Yoshida et al. , 2009). It has been shown that ANT are potent 
antioxidants, and prove to be effective scavengers of reactive oxygen species 
(ROS) and reactive nitrogen species (RNS) (Kahkonen and Heinonen, 2003, 
Kahkonen et al. , 2001), having a clear neuroprotective role (Min et al. , 2011).  
There is evidence that ANT have beneficial effects on memory and cognition 
(Shukitt-Hale et al., 2009) improving the memory in old rats and humans 
(Andres-Lacueva et al., 2005, Krikorian et al., 2010).  
Acetylcholinesterase (AChE) is an important regulatory enzyme that 
rapidly hydrolyses the neurotransmitter acetylcholine (ACh) released by the  
cholinergic neurons (Paleari et al. , 2008). Several experimental  and clinical 
studies clearly indicate an undisputed major role of ACh in the regulation of 
cognitive functions (Blokland, 1995). Recently, several therapeutic strategies 
that enhance A hE activity have been implemented to ameliorate cognitive 
disorders. Cognitive disorders also affect the generation of membrane 
potentials and the influx of neuronal Ca2+ (Berrocal et al. , 2009, Mata et al. , 
2011).  
The Na+,K+-ATPase and the Ca2+-ATPase are key enzymes in the 
maintenance of electrolyte gradients in excitable cells and neurons (Jimenez et 
al., 2010, Panayiotidis et al., 2010). The former enzyme is responsible for the 
active transport of Na+ and K+, and it is necessary to maintain the ionic gradient 
across membranes and thus it is essential to regulate neuronal excitability 
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(Jimenez, Sanchez, 2010, Jorgensen et al. , 2003, Kaplan, 2002). The Ca2+-
ATPase is one of the most powerful modulators of intracellular Ca2+ levels 
(Casteels et al. , 1991, Huang et al. , 2010, Raeymaekers and Wuytack, 1991). 
The transient changes in intracellular Ca2+ levels regulate  a wide variety of 
cellular processes and cells employ both intracellular and extracellular sources 
of Ca2+ for the activation of signaling pathways and regulation of many 
physiological and pathological processes (Huang, Nagaraja, 2010, Missiaen et 
al. , 2000a, Missiaen et al. , 2000b, Ruknudin and Lakatta, 2007). 
Alzheimer’s disease (AD) is the most common cause of dementia in the 
elderly, and this disease is characterized by abnormalities in glucose 
metabolism, reduced glucose utilization and levels of energy rich phosphates 
(Hoyer, 2004a, b). The intracerebroventricular (icv)  injection of STZ in rats has 
been used  as a model of sporadic dementia of AD (Sharma and Gupta, 2001) 
since it mimics many pathological processes of the disease as impaired brain 
glucose and energy and leads to progressive deficits in learning and memory 
(Lannert and Hoyer, 1998) 
Considering that AD is the most prevalent neurodegenerative disease 
worldwide in older adults, we sought to investigate if anthocyanin has the ability 
to prevent memory deficits induced by icv administration of STZ. We also 
evaluated the levels of nitrite/nitrate and the activities of enzymes AChE, 
Na+,K+-ATPase and Ca2+-ATPase, which are known to be altered in AD. 
 
2. Material and Methods 
2.1. Chemicals 
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Acetylthiocholine, Trizma Base, Acetonitrile, Percoll, Coomassie 
Brilliant Blue G and Streptozotocyn (STZ) were purchased from Sigma 
Chemical Co (St Luis, MO, USA).  Anthocyanins was extracted and purified 
from grape skin and are commercially available by Christian Hansen A/S. All 
other reagents used in the experiments were of analytical grade and of the 
highest purity.  
 
2.2 Animals 
Male Wistar rats (3 month year old) weighing 350–400 g were used in 
the study. They were kept in the Central Animal House of Federal University of 
Santa Maria in colony cages at an ambient temperature of 25±2 °C and relative 
humidity 45–55% with 12 h light/dark cycles. They had free access to standard 
rodent pelleted diet and water ad libitum. All procedures were carried out ac-
cording to NIH Guide for Care and Use of Laboratory Animals, and Brazilian 
Society for Neuroscience and Behavior (SBNeC) recommendations for animal 
care. This work was approved by the ethical committee of Federal University of 
Santa Maria (23081.003601/2012-63). 
 
2.3. Administration of drugs to animals 
2.3.1. Intracerebroventricular (icv) injection of streptozotocin  
Adult male Wistar rats (300–350g) were anaesthetized with thiopental 
(180mg/kg). The head was placed in position in the stereotaxic apparatus and a 
midline sagittal incision was made in the scalp. The stereotaxic coordinates for 
lateral ventricle (Paxinos and Watson, 1986) were measured accurately as 
anterio-posterior -0.8mm, lateral 1.5mm and dorso-ventral, -4.0mm relative to 
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bregma and ventral from dura with the tooth bar set at 0 mm. Through a skull 
hole, a 28-gauge Hamilton® syringe of 10 μl attached to a stereotaxic 
apparatus and piston of the syringe was lowered manually into each lateral 
ventricle. We used 4 different groups: control (CTRL), anthocyanin (ANT), 
streptozotocin (STZ), and streptozotocin plus anthocyanin (STZ+ANT). The STZ 
groups received bilateral icv injection of streptozotocin (3 mg/kg, body weight) 
which was dissolved in citrate buffer (pH 4.4) (Tiwari et al. , 2009). The 
concentration of STZ in citrate buffer was adjusted so as to deliver 5 μl/injection 
site of the solution. Rats in the control group received icv injection of same 
volume of citrate buffer as in STZ treated (Scheme 1). 
 
2.3.2 Drug administration 
Seven to ten animals per group were usually tested in the experiments.  
Rats were treated by gavage with anthocyanin (200 mg/kg body weight) daily 
per 7 days (around 10 a.m.). The dose of anthocyanin was chosen on the basis 
of previous studies indicating neuroprotection (Gutierres et al. , 2012b, Manach 
et al. , 2004, Saija et al. , 1990, Varadinova et al. , 2009). The control groups 
received only vehicle (2ml/kg gavage of saline, daily per 7 days). 
 
2.4 Behavioral procedure 
2.4.1 Elevated plus maze task 
At the last day of anthocyanin treatment (7th day), the anxiolytic-like 
behavior was evaluated using the task of the elevated plus maze as previously 
described (Frussa-Filho et al. , 1999, Rubin, Albach, 2000a). The apparatus 
consists of a wooden structure raised to 50 cm from the floor. This apparatus is 
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composed of 4 arms of the same size, with two closed-arms (walls 40 cm) and 
two open-arms. Initially, the animals were placed on the central platform of the 
maze in front an open arm. The animal had 5 minutes to explore the apparatus, 
and the time spent and the number of entries in open and closed-arms were 
recorded. The apparatus was thoroughly cleaned with 30% ethanol between 
each session.  
 
2.4.2 Inhibitory avoidance task 
The animals were subjected to training in a step-down inhibitory 
avoidance apparatus as previously described (Rubin et al. , 2000b). After that 
the animals received icv-STZ (3 mg/kg). Twenty four hours after the training the 
animals were subjected to test in a step-down inhibitory avoidance task. Briefly, 
the rats were subjected to a single training session in a step-down inhibitory 
avoidance apparatus, which consisted of a 25×25×35-cm box with a grid floor 
whose left portion was covered by a 7×25-cm platform, 2.5 cm high. The rats 
were placed gently on the platform facing the rear left corner, and when the rat 
stepped down with all four paws on the grid, a 3-s 0.4-mA shock was applied to 
the grid. Retention test took place in the same apparatus 24 h later. Test step-
down latency was taken as a measure of retention, and a cut-off time of 300s 
was established. 
 
2.4.3 Open field 
Immediately after the inhibitory avoidance test session, the animals 
were transferred to an open-field measuring 56×40×30 cm, with the floor 
divided into 12 squares measuring 12×12 cm each. The open field session 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
8 
 
lasted for 5 min and during this time, an observer, who was not aware of the 
pharmacological treatments, recorded the number of crossing responses and 
rearing responses manually. This test was carried out to identify motor 
disabilities, which might influence inhibitory avoidance performance at testing 
(Gutierres et al. , 2012a). 
 
2.4.4 Foot shock sensitivity test 
Reactivity to shock was evaluated in the same apparatus used for 
inhibitory avoidance, except that the platform was removed and was used to 
determine the flinch and jump thresholds in experimentally naïve animals 
(Berlese et al. , 2005, Rubin et al. , 2000a). The animals were placed on the 
grid and allowed a 3 min habituation period before the start of a series of 
shocks (1s) delivered at 10 s intervals. Shock intensities ranged from 0.1 to 0.5 
mA in 0.1 mA increments. The adjustments in shock intensity were made in 
accordance with each animal's response. The intensity was raised by one unit 
when no response occurred and lowered by one unit when a response was 
made. A flinch response was defined as withdrawal of one paw from the grid 
floor, and a jump response was defined as withdrawal of three or four paws. 
Two measurements of each threshold (flinch and jump) were made, and the 
mean of each score was calculated for each animal. 
 
2.5 Brain tissue preparation 
After behavioral tests, the animals were anesthetized under halothane 
atmosphere, euthanized by decapitation and the brain was removed and 
separated into cerebral cortex and hippocampus and placed in a solution of 
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Tris–HCl 10 mM, pH 7.4, on ice. The brain structures were gently homogenized 
in a glass potter in Tris–HCl solution. Aliquots of resulting brain structure 
homogenates were stored at −20°C until utilization (Gutierres, Carvalho, 
2012a). Protein was determined previously in a strip that varied for each 
structure: cerebral cortex (0.7 mg/ml) and hippocampus (0.8 mg/ml), and 
determined by Coomassie blue method as previously described (Bradford, 
1976), using bovine serum albumin as standard solution. 
 
2.6 Isolation of synaptosomes with a discontinuous Percoll gradient 
Synaptosomes were isolated essentially as previously described (Nagy 
and Delgado-Escueta, 1984), with a minor modification (Gutierres et al. , 2012c) 
using a discontinuous Percoll gradient. The cerebral cortex and hippocampus 
were gently homogenized in 10 volumes of an ice-cold medium (medium I) 
containing 320 mM sucrose, 0.1 mM EDTA and 5 mM HEPES, pH 7.5, in a 
motor driven Teflon-glass homogenizer and then centrifuged at 1,000xg for 10 
min. An aliquot of 0.5 mL of the crude mitochondrial pellet was mixed with 4.0 
mL of an 8.5% Percoll solution and layered into an isosmotic discontinuous 
Percoll/sucrose gradient (10%/16%). The synaptosomes that banded at the 
10/16% Percoll interface were collected with a wide-tip disposable plastic 
transfer pipette. The synaptosomal fraction was washed twice with an isosmotic 
solution consisting of 320 mM sucrose, 5.0 mM HEPES, pH 7.5, and 0.1 mM 
EDTA by centrifugation at 15,000 g to remove the contaminating Percoll. The 
pellet of the second centrifugation was resuspended in an isosmotic solution to 
a final protein concentration of 0.4-0.6 mg/ml. Synaptosomes were prepared 
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fresh daily and maintained at 0º-4º throughout the procedure and used to 
measure Ca2+-ATPase and AChE activities. 
 
2.7. Assay of Lactate Desydrogenase (LDH) 
The integrity of the synaptosomes preparations was confirmed by the 
lactate dehydrogenase (LDH) activity, which was obtained after synaptosome 
lysis with 0.1 % Triton X-100 and comparing it with an intact preparation, using 
the Labtest kit (Labtest, Lagoa Santa, MG, Brasil). 
 
2.8. Determination of AChE activity in brain   
The AChE enzymatic assay was determined by a modification of the 
spectrophotometric method (Rocha et al., 1993) as previously described 
(Ellman et al. , 1961). The reaction mixture contained 100 mM K+-phosphate 
buffer, pH 7.5 and 1 mM 5,5′-dithiobisnitrobenzoic acid (DTNB). The method is 
based on the formation of the yellow anion, 5,5′-dithio-bis-acid-nitrobenzoic, 
measured by absorbance at 412 nm during 2min incubation at 25°C. The 
enzyme (40–50 μg of protein) was pre-incubated for 2 min. The reaction was 
initiated by adding 0.8 mM acetylthiocholine iodide (AcSCh). All samples were 
run in triplicate and the enzyme activity was expressed in μmol AcSCh/h/mg of 
protein.  
2.9. Analysis of Gene Expression using semiquantitative RT-PCR 
The analysis of AChE expression was carried out using 
semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR). 
The hippocampus and cerebral cortex were dissected under sterile conditions, 
and total RNA was extracted using the TRIzol® Reagent (Invitrogen, Carlsbad, 
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CA, USA) according to the manufacturer’s instructions. The RNA was quantified 
by spectrophotometry, and cDNA was synthesized using the ImProm-II™ 
Reverse Transcription System (Promega). PCR reactions for the AChE and β-
actin genes were performed using 0.1 μM of the appropriate primers (AChE 
forward: 5′- GAC TGC CTT TAT CTT AAT GTG -3′ and reverse: 5′- CGG CTG 
ATG AGA GAT TCA TTG -3′; β-actin forward 5′-TAT GCC AAC ACA GTG CTG 
TCT GG-3′; and reverse 5′-TAC TCC TGC TTC CTG ATC CAC AT-3′) (see 
Table 2), 0.2 μM dNTP, 2 mM MgCl2, and 0.1 U Platinum Taq DNA polymerase 
(Invitrogen) in a total volume of 25 μL for AChE and 20 μL for β-actin (Da Silva 
et al. , 2008). The following conditions were used for the PCR reactions: 1 min 
at 94°C; 1 min at the annealing temperature (54°C for β-actin and 55°C for 
AChE) and 1 min at 72°C for 35 cycles. Post-extension at 72°C was performed 
for 10 min. For each set of PCR reactions, a negative control was also included. 
The PCR products (AChE, 785 bp; β-actin, 210 bp) were analyzed on a 1.5% 
agarose gel containing GelRed® (Biotium) and visualized under ultraviolet light. 
The Low DNA Mass Ladder (Invitrogen) was used as a molecular marker, and 
normalization was performed using β-actin as the constitutive gene. All PCR 
analysis was run in triplicates, including negative controls (in which no reverse 
transcriptase nor cDNA-containing samples were added in the PCR mix). No 
background fluorescence was observed when control samples were analyzed 
(data not shown)." 
 
2.10. Na+,K+-ATPase activity measurement 
Na+,K+-ATPase activity was measured as previously described (Wyse 
et al. , 2000) with minor modifications (Carvalho et al. , 2012). Briefly, the assay 
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medium consisted of (in mM) 30 Tris-HCl buffer (pH 7.4), 0.1 EDTA, 50 NaCl, 5 
KCl, 6 MgCl2 and 50 μg of protein in the presence or absence of ouabain (1 
mM), in a final volume of 350 μL. The reaction was started by the addition of 
adenosine triphosphate to a final concentration of 3 mM. After 30 min at 37ºC, 
the reaction was stopped by the addition of 70 μL of 50% (w/v) trichloroacetic 
acid. Saturating substrate concentrations were used, and reaction was linear 
with protein and time. Appropriate controls were included in the assays for non-
enzymatic hydrolysis of ATP. The amount of inorganic phosphate (Pi) released 
was quantified colorimetrically, as previously described (Fiske and Subbarow, 
1927), using KH2PO4 as reference standard. Specific Na
+,K+-ATPase activity 
was calculated by subtracting the ouabain-insensitive activity from the overall 
activity (in the absence of ouabain) and expressed in nmol of Pi/min/mg of 
protein. 
 
2.11. Ca2+-ATPase activity measurement 
Ca2+-ATPase activity was measured as previously described (Rohn et 
al. , 1993) with minor modifications (Trevisan et al. , 2009). Briefly, the assay 
medium consisted of (in mM) 30 Tris-HCl buffer (pH 7.4), 0.1 EGTA, 3 MgCl2 
and 100 μg of protein in the presence or absence of 0.4 CaCl2, in a final volume 
of 200 μL. The reaction was started by the addition of adenosine triphosphate to 
a final concentration of 3 mM. After 60 min at 37ºC, the reaction was stopped by 
the addition of 70 μL of 50% (w/v) trichloroacetic acid. Saturating substrate 
concentrations were used, and reaction was linear with protein and time. 
Appropriate controls were included in the assays for non-enzymatic hydrolysis 
of ATP. The amount of inorganic phosphate (Pi) released was quantified 
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colorimetrically, as previously described (Fiske and Subbarow, 1927), using 
KH2PO4 as reference standard. The Ca
2+-ATPase activity was determined by 
subtracting the activity measured in the presence of Ca2+ from that determined 
in the absence of Ca2+ (no added Ca2+ plus 0.1 mM EGTA) and expressed in 
nmol of Pi/min/mg of protein. 
 
2.12 [H3] Flunitrazepam binding assay 
To determine if the effect of anthocyanins can be mediated by the 
GABAA/BDZ complex, we performed a specific binding assay of the BDZ site of 
GABAA receptors using [
3H]flunitrazepam according to a previous study (Della-
Pace et al., 2013).  Cerebral cortex from each animal was thawed and 
homogenized in 10 ml of homogenization buffer A (10 mM Tris-HCl, 300 mM 
sucrose, and 2 mM EDTA, pH 7.4) per gram of tissue. This homogenate was 
centrifuged at 1,000 X g for 10 min at 4°C. The resulting supernatant was 
centrifuged at 16,000 X g for 20 min at 4°C. The resulting pellet was then 
resuspended in 1 ml of homogenization buffer and frozen at - 70°C until 
analyzed.  
 
2.12.1 Radioligand binding assay 
[3H] flunitrazepam binding to benzodiazepinic site of GABAA receptors 
was determinedby first washing the cell membrane preparation as follows: 
individual aliquots were diluted with five volumes of wash buffer B (50 mM Tris-
HCl and 2 mM EDTA, pH 7.4), mixed, and centrifuged at 16,000 X g for 10 min 
at 4°C, and the samples were incubated for 30 min at 37°C. This washing 
procedure was repeated twice, and the final pellet was resuspended in binding 
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assay buffer C (20 mM HEPES and 1 mM EDTA, pH 7.4). The protein 
concentration of each sample was determined by a spectrophotometric protein 
dye-binding assay based on the method of Bradford (1976), using bovine serum 
albumin as the standard. The incubation was carried out in duplicate in 
polycarbonated tubes (total volume 500 µL) containing 50 mM Tris–HCl (pH 
7.4), 0.5 mg of protein membrane. Diazepam (0.1 µM) was used as a positive 
control. Incubation was started by adding 1 nM [3H] flunitrazepam 
(85,8Ci/mmol), and run at ice for 60 min. The reaction was stopped by vacuum 
filtration and each filter was washed with 15 mL of cold 10 mM Tris–HCl buffer. 
Filters were individually placed in polycarbonated tubes and 1 mL of scintillation 
liquid was added. Radioactivity was determined using a Packard Tri-Carb 
2100TR liquid scintillation counter. Non-specific binding was determined by 
adding 1 µM diazepam to the medium in parallel assays. Specific binding was 
considered as the difference between total binding and non-specific binding. 
Results were expressed as percentage of specific binding. 
 
2.13. Assay of nitrite plus nitrate (NO2 plus NO3)  
For NOx determination, an aliquot (200 μl of samples) was homoge-
nized in 200mM Zn2SO4 and acetonitrile (96%, HPLC grade). After, the homog-
enate was centrifuged at 16,000 xg for 20min at 4°C and supernatant was sepa-
rated for analysis of the NOx content as previously described (Miranda et al. , 
2001). The resulting pellet was suspended in NaOH (6M) for protein determina-
tion. 
 
2.14. Glucose analysis 
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The glucose levels were measured using standard enzymatic methods 
from Ortho-Clinical Diagnostics® reagents on the fully automated analyzer 
(Vitros 950® dry chemistry system; Johnson & Johnson, Rochester, NY, USA). 
2.15. Statistical analysis 
Statistical analysis of training and test step-down latencies was carried 
out by the Scheirer–Ray–Hare extension of the Kruskal–Wallis test 
(nonparametric two-way ANOVA). The open field, binding assay and foot shock 
sensitivity was analyzed by one-way ANOVA following by student Newman-
Keuls. The other tests were analyzed by two-way ANOVA, followed by Tukey 
test, and considered P<0.05 or P<0.001 as significant difference in all 
experiments. 
 
3. Results 
3.1 Glucose Levels  
During the complete study there were no differences in body weight and 
water consumption in all groups (data not shown). There was no significant 
difference between the mean peripheral glucose levels after 3 mg/kg icv-STZ 
groups and citrate buffer (pH 4.4) icv injection groups. The mean peripheral 
glucose levels were 109.36 ± 2.20 CTRL group, 102.66±2.13 ANT group, 
110.44 ± 1.92 STZ group and 106.77±2.09 STZ+ANT group, respectively, 
indicating that the dose was sub diabetogenic (Table 3).  
 
3.2 Behavioral tests 
3.2.1 Anthocyanin prevents the impairment of memory induced by STZ. 
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In this study we used 4 groups of animals: control (CTRL), anthocyanin 
(ANT), streptozotocin (STZ), and streptozotocin plus anthocyanin (STZ+ANT). 
Figure 1 shows the effect of ANT treatment on the STZ-induced memory 
deficits, in the step-down latencies. Statistical analysis of Scheirer–Ray–Hare 
test (nonparametric two-way ANOVA) showed a significant difference between 
STZ (3 mg/kg) vs ANT (200 mg/kg) or vehicle interaction (CTRL), revealing that 
treatment with ANT prevented the impairment of memory induced by STZ [H2 = 
9,75; P< 0.01; Figure 1D]. Statistical analysis of the data obtained during 
training showed no difference between the different groups (Figure 1C).  
Although, motivational disparities in the training session may account 
for differences in inhibitory avoidance testing, experiments were performed to 
assess whether STZ or ANT affected shock sensitivity threshold and locomotor 
capacity of the animals. Statistical analysis of open-field data (one-way ANOVA) 
revealed that STZ did not alter the number of crossing (F (3,42)=0.11, P>0.05; 
Figure 1A) or rearing (F (3,42)=1.82, P>0.05; Figure 1B) responses in a 
subsequent open-field test session, suggesting that neither STZ nor ANT 
caused gross motor disabilities in this task. Moreover, STZ did not alter foot 
shock sensitivity, as demonstrated by the similar flinch and jump thresholds 
exhibited by the animals. In table 4 it can be seen that  neither  ANT+STZ  
animals nor STZ animals were affected in their  motor performances and foot 
shock sensitivity: flinch [F (3,30)= 1.33; P>0.05], jump [F (3,30)= 1.66; P>0.05] 
and vocalization [F (3,30)= 1.76; P>0.05]. 
 
3.2.2 Effect of STZ and anthocyanin treatment on anxiolytic-like behavior 
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Figure 2 shows the effect of the treatment with anthocyanin and STZ on 
anxiolytic-like behavior in the elevated plus maze task. Statistical analysis (two-
way ANOVA) showed a significant CTRL or STZ (3 mg/kg) vs CTRL or ANT 
(200 mg/kg) interaction to time spent (s) in open arms [F (1,41)= 6.264; P<0.05; 
Figure 2D] and time in closed arms [F (1,41)= 4.925; P<0.05; Figure 2C], 
revealing that treatment with ANT prevented the anxiogenic behavior induced 
by STZ. However, no significant differences in the number of entries in open 
arms [F (1,41)= 0.279; P>0.05; Figure 2B] and in the number of entries in all 
arms [F (1,41)= 0.68; P>0.05; Figure 2A] were observed. The number of total 
entries in arms suggests that neither icv-STZ nor ANT animals had altered 
locomotor activity in the elevated plus maze task.   
3.3 Binding of [3H] flunitrazepam to benzodiazepinic site assay 
Since we observed an anxiolytic effect of ANT in the elevated plus maze 
task, we decided to investigate whether the compound can alter the binding of 
[3H] flunitrazepam to the benzodiazepinic site of GABAA receptor. The results 
presented in Figure 3 reveal that the ANT (100µM) reduced by 43% the [3H] 
flunitrazepam binding to benzodiazepinic site of GABAA receptors [F (2,17)= 
47.890; P<0.0001] and this result demonstrates that ANT can interact to GABAA 
receptors.   
 
3.4 Activity and expression of acetylcholinesterase  
3.4.1 Anthocyanin prevents the increase in AChE activity induced by STZ. 
Previous studies report cholinergic impairments in cognitive disorders by 
quantification of acetylcholinesterase (AChE) activity. Therefore, we investigat-
ed whether ANT restores AChE activity in the model of SDAT. Figure 4 shows 
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the effect of ANT and STZ on the AChE activity in cerebral cortex and hippo-
campus, both in S1 and synaptosomes of rats. We found a significant CTRL or 
STZ (3 mg/kg) vs CTRL or ANT (200 mg/kg) interaction, suggesting that the 
ANT treatment prevents the increase in AChE activity in S1 fraction of cerebral 
cortex [F= (1,28)= 7.973; P<0.05] and hippocampus [F (1,28)= 4.995; P<0.05] 
(Figure 4A) induced by icv-STZ.  
Importantly, synaptosome fraction analysis showed a significant CTRL or 
STZ (3 mg/kg) vs CTRL or ANT (200 mg/kg) interaction, suggesting that the 
ANT treatment prevents the increase in AChE activity in the synaptosomes of 
cerebral cortex [F (1,28)= 4.760; P<0.05] and hippocampus [F (1,28)= 8. 434; 
P<0.01](Figure 4B) induced by icv-STZ. 
3.4.2 Effect of STZ and anthocyanin treatment on the AChE expression in the 
cortex and hippocampus of rats. 
Figure 5 shows the effect of ANT and STZ on the AChE expression in 
cerebral cortex and hippocampus of rats. No significant differences in AChE 
expression between groups were observed in the cerebral cortex [F (1,8)= 
0.423; P>0.05] and hippocampus [F (1,8)= 0.140; P>0.05].  
 
3.5 Anthocyanin prevents the decrease of Na+,K+-ATPase and increase of Ca2+-
ATPase activity induced by STZ.  
Na+,K+-ATPase and Ca2+-ATPase are enzymes involved in the control of 
neurotransmission, regulating the membrane potential and extracellular calcium 
concentrations, respectively. Figure 6 shows the effect of ANT and STZ on the 
activity of Na+,K+-ATPase and Ca2+-ATPase in cerebral cortex and 
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hippocampus of rats. Statistical analysis (two-way ANOVA) showed a significant 
CTRL or STZ (3 mg/kg) vs CTRL or ANT (200 mg/kg) interaction, suggesting 
that the ANT treatment prevents the decrease in Na+,K+-ATPase activity in the 
cerebral cortex [F (1,28)= 17.760; P<0.001] and hippocampus [F (1,28)= 4.978, 
P<0.05] induced by icv-STZ (Figure 6A). 
Additionally, two-way ANOVA showed a significant CTRL or STZ (3 
mg/kg) vs CTRL or ANT (200 mg/kg) interaction, suggesting that the ANT 
treatment prevents the increase of Ca2+-ATPase activity in the cerebral cortex 
[F (1,28)= 5.671; P<0.05] and hippocampus [F (1,28)= 5.272; P<0.05] induced 
by icv-STZ (Figure 6B).  
 
3.6 NOx levels determination  
Anthocyanins are known by their antioxidant properties, so in this set of 
experiments we investigated if ANT alters nitrite/nitrate content in the brain of 
rats. Figure 7 shows the effect of ANT and STZ on the NOx levels production in 
cerebral cortex and hippocampus. Statistical analysis (two-way ANOVA) 
showed a significant CTRL or STZ (3 mg/kg) vs CRTL or ANT (200 mg/kg) 
interaction, suggesting that the ANT treatment prevents the  increased NOx 
levels both in cerebral cortex [F (1,28)= 8.583; P<0.05] and hippocampus [F 
(1,28)= 23.350; P<0.0001] induced by icv-STZ.  
 
4. Discussion 
Anthocyanins are flavonoids found in fruits and fruit juices, and have the 
capacity to improve memory (Harborne and Williams, 2001, Williams and 
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Grayer, 2004, Williams et al. , 2008).  Several evidence has demonstrated that 
ANT are able to improve memory of old rats in Morris water maze (Andres-
Lacueva, Shukitt-Hale, 2005), and of mice in the inhibitory avoidance task 
(Barros et al. , 2006) and eldery humans (Krikorian, Shidler, 2010). There is 
evidence that ANT prevents neurotoxicity induced by: i)  ethanol in developing 
brain mice (Ke et al. , 2011), ii) reperfusion damage model of cerebral ischemia 
(Min, Yu, 2011, Shin et al. , 2006), iii) deleterious effects found in models of 
Parkinson's (Kim et al. , 2010) and Alzheimer's disease (Shih et al. , 2010).  
Additionally, there was a large number of studies’ indicating the 
neuroprotective role of ANT, since studies have shown that ANT can be 
transported across biological membranes (Passamonti et al., 2005, Talavera et 
al.,2005). There are studies announcing gastric absorption and neuroprotective 
effects of ANT-rich foods, but there is a gap in the knowledge concerning, for 
example, gastric or ANT transport across the blood-brain barrier (BBB) (Kalt et 
al.,2008). Another important factor affecting ANT bioavailability and 
pharmacokinetic properties are their possible ingestion as pigments 
(anthocyanin derivatives), especially when considering wine consumption. A 
recent work had already indicated that anthocyanin pyruvic-acid adducts can 
rapidly reach rat plasma 15min after oral administration of 400 mg/kg (Faria et 
al., 2009a, Faria et al., 2009b). Thus, we investigated whether this natural 
compound could prevent some alterations found in a model of SDAT induced by 
icv-STZ injection.  
Furthermore, a subdiabetogenic dose of STZ (3mg/kg) to rodents 
causing a progressive memory impairment, loss and synaptic dysfunction 
(Lannert and Hoyer, 1998, Pinton et al. , 2010). Thus, there was no significant 
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difference on the mean peripheral glucose levels between CTRL and icv-STZ 
groups (Table 3). Our results indicated that icv-STZ impaired the acquisition of 
memory in rats trained on the inhibitory avoidance task. Interestingly, we found 
out that ANT at 200 mg/kg  for 7 days, did not  affect the memory of rats and 
prevented the memory deficits induced by icv-STZ (Figure. 1D), as assessed by 
the inhibitory avoidance task. Furthermore, previous studies from our laboratory 
demonstrated that the dose of 200 mg/kg ANT antagonized scopolamine-
induced performance deficits in rats (Gutierres, Carvalho, 2012b) suggesting 
that ANT have a close interaction with cholinergic system.   
 Immediately after inhibitory avoidance test, the animals were subjected 
to an open-field test which is widely used for evaluating motor abnormalities 
(Belzung and Griebel, 2001). The open field session revealed that the treatment 
with icv-STZ or ANT did not alter spontaneous locomotor activity (Figure 1A, B). 
Moreover, we observed that the rats of different groups did not show altered 
shock sensitivity (Table 4), as verified by their similar flinch, jump and 
vocalization thresholds. These data suggest that neither STZ nor ANT 
administration caused motor disabilities or altered foot shock sensitivity, 
excluding their possibility of interference in step-down latencies of inhibitory 
avoidance task.  
Besides to assessing the acquisition memory in the inhibitory avoidance 
task, we also measured the anxiolytic-like behavior by the elevated plus maze 
task, commonly used to study anxiety-related behavior in rodents (Belzung and 
Griebel, 2001). Our results showed a higher anxiety in icv-STZ group (3 mg/kg) 
(Figure 2C; D) which is in accordance with previous observations that mice 
subjected to icv-STZ, in short time (7days) and long time (21 days) treatments, 
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have a rise increase in anxious behavior (Pinton et al. , 2011). We found an 
anxiolytic effect of treatment of ANT that was observed by time in closed arm. 
However, ANT did not change the number of entries and time spent in open 
arms. We suggest to investigate anxiolytic effects of anthocyanins per se would 
be important to select a range of doses. Additionally, the dose chosen in this 
study was able to prevent the anxiogenic behavior caused by icv-STZ 
administration (Figure 2C, D). We believe that the mechanism by which ANT 
plays anxiolytic effect result in part from an interaction with the GABAergic 
system, because the ANT significantly displace the specific binding of [3H] 
flunitrazepam to benzodiazepinic site of the GABAA receptor (Figure 3). Several 
molecular interactions can be addressed to explain the displacement of specific 
binding of [3H] flunitrazepam to benzodiazepinic site of the GABAA including the 
indirect effect of ANT on GABA receptor currents and the binding of ANT at 
orthosteric or allosteric GABAA binding sites. So, even if we can not assert 
where ANT is specifically binding, it is clear that is closely related to GABAergic 
pathway. This work is the first to describe a possible location where this 
compound may act to promote an anxiolytic effect, suggesting that ANT may be 
considered an important pharmacological agent in situations of anxiety.  
The pivotal role of cholinergic system in memory is further underlined by 
use of AChE inhibitors in AD to prevent memory decline. In this study, we found 
that icv-STZ group showed an increase in AChE activity in supernatant and 
synaptosomes in relation to all tested groups (Figure 4). This finding is in 
conformity with the previous studies showing increase in AChE activity upon 
icv-STZ administration (Awasthi et al. , 2010, Tota et al. , 2010, Tota et al. , 
2009), but not AChE expression (Figure 5). However, we cannot exclude that 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
23 
 
the icv-STZ injection can cause changes in the AChE mRNA expression, since 
studies with administration of icv-STZ for 21 days was able to alter AChE 
expression in the cerebral cortex and hippocampus of rats (Tota et al. , 2012) 
and the exposure to STZ in this study was 7 days. In addition, the impairment in 
insulin signaling, reduced cholineacetyltransferase (ChAT) activity and 
increased oxidative stress induced by icv-STZ injection were associated with 
the upregulation of AChE in the brain of rats (de la Monte et al. , 2006, Lester-
Coll et al. , 2006). In the present study, we observed that ANT was able to 
prevent the AChE upregulation in hippocampus and cerebral cortex of icv-STZ 
animals, without affect per se the AChE activity. This effect of ANT can be 
attributed, at least in part, to its potent antioxidant effect.  
While it is not evaluated whether glial or neuronal Na+,K+-ATPase and 
Ca2+-ATPAse are preferentially affected by STZ, it is conceivable that STZ may 
alter both cell types. If this was the case, icv-STZ could alter Na+, K+ and Ca2+ 
intracellular gradients, facilitating neuronal depolarization and impairing sodium 
and potassium gradient-dependent transport processes, such as 
neurotransmitter uptake (Benarroch, 2011, Gether et al. , 2006, Gouaux, 2009). 
In this view, it is known that a decreased activity and expression of Na+, K+-
ATPase, directly affects the signaling of neurotransmitters, impairing learning 
and memory, as well as locomotor activity and anxiety behavior of rats (dos 
Reis et al. , 2002, Lingrel et al. , 2007, Moseley et al. , 2007). In vitro studies 
showed that the inhibitor of Na+,K+-ATPase, ouabain, increases the Ca2+ influx 
into slices of rats brain (Fujisawa et al. , 1965), induces the release of glutamate 
by reverse transport of Na+ (Li and Stys, 2001) and cause excitotoxicity in 
hippocampal neurons (Lees et al. , 1990). Corroborating these findings, our 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
24 
 
study showed that icv-STZ administration decreased Na+, K+-ATPase activity 
and increased Ca2+-ATPase activity (Figure 6), suggesting that a disturbance in 
the electrolytic concentrations of Na+ and Ca2+ could lead to excitotoxicity and 
neuronal death in animals icv-STZ injected.   
Furthermore, it was also found that the inhibition of Na+,K+-ATPase 
increase NMDA-mediated currents in the hippocampus (Zhang et al. , 2011). It 
is known that NMDA receptor activation increases the nitric oxide (NO) 
synthesis by increasing nitric oxide synthase activity (NOS) (Prast and Philippu, 
2001, Sattler et al. , 1999). NO is a retrograde messenger which diffuses 
through the cellular membranes and activation of guanylate cyclase and PKG 
(East and Garthwaite, 1991). Previous studies have demonstrated that 
activation of NOS and synthesis of NO are related with the reduction of Na+, K+-
ATPase activity (Boldyrev et al. , 2003, Boldyrev et al. , 2004, Carvalho, Mello, 
2012). Our results, show that icv-STZ administration increases the nitrate/nitrite 
levels (Figure 7), so these findings may be related to the reduction of Na+, K+-
ATPase in two ways:  1- NO can inhibit the Na+,K+-ATPase activity through its 
binding to thiol groups, generating S-nitrosothiol and consequently leading to 
the formation of  nitrous compounds (Boldyrev and Bulygina, 1997, Boldyrev et 
al. , 1997, Lipton et al. , 1993, Lipton et al. , 1994, Takeguchi et al. , 1976); 2- 
activation of signaling pathway related with  NOS/cGMP/PKG (Carvalho, Mello, 
2012). 
These studies have stated that in addition to ANT antioxidant effects, 
these compounds decrease the levels of NO (Blokland and Jolles, 1993, 
Juranic and Zizak, 2005). The data presented in this paper demonstrates that 
ANT prevented the augment of NOx levels induced by icv-STZ. Previous 
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studies have shown that ANT is able to decrease the iNOS expression as well 
as NO production in macrophages and JC77 cells exposed to 
lipopolysaccharide induced inflammation (Pergola et al. , 2006, Wang et al. , 
2008). This leads us to believe that the ANT might prevent excitotoxic 
mechanisms related with NO synthesis, since the overproduction of reactive 
nitrogen species (RNS) results in “nitrosative” stress that contributes to several 
pathological processes that underlie neurodegenerative and inflammatory 
diseases (Rutkowski et al. , 2007, Valko et al. , 2007).  
Besides ANT antioxidant properties we can not discard other ANT 
neuroprotective mechanisms in the prevention of the increase in NOx induced 
by STZ such as for the affinity of ANT to GABAA receptors. Studies have shown 
that compounds which potentiate GABAA receptors (benzodiazepines) prevent 
the increase of NO induced by NMDA administration in the cerebellum of rats 
(Fedele et al. , 2000). Furthermore, the activation of GABAA receptors protects 
neurons against Aβ toxicity in AD-affected regions in mammalian brain (Paula-
Lima et al. , 2005). Recent studies have found a significant reduction of GABA 
currents in AD brains, associated with reductions of mRNA and protein of the 
principal GABA receptor subunits normally present in the temporal cortex, and 
these findings can support a functional remodeling of GABAergic 
neurotransmission in the human AD brain (Limon et al., 2012). 
Thus, our results suggest that the ANT could exert beneficial actions, 
preventing the increase in AChE activity and memory loss induced by icv-STZ. 
Interestingly, our results showed, for the first time that ANT has affinity for 
GABAA receptors, which may explain the anxiolytic effect per se and counteract 
the increased anxiety of icv-STZ animals. Moreover, additional therapeutic 
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implications can be attributed to ANT through its capacity to modulate NO 
production and regulate Na+, K+-ATPase and Ca+-ATPase activities in 
pathological situations. More experiments are already being conducted to 
investigate possible biochemical targets of flavonoids, as ANT, in the SDAT. 
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Legends 
Table 1. Structural identification of anthocyanins. 
 
Table 2. The primers used for the gene amplification 
 
Table 3.  Effects of anthocyanin (200mg/kg) treatment and icv-STZ (3mg/kg) 
injection on glucose (mg/dL) levels. Data are reported as means ± S.E.M. with 
8-10 rats for group. ANOVA (one-way) followed by Tukey test. 
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Table 4. Effect of anthocyanin (200 mg/kg) and icv-STZ (3 mg/kg) on foot shock 
sensitivity (flinch, jump and vocalization). Data are reported as means ± S.E.M. 
with 8-10 rats for group. ANOVA (two-way) followed by Tukey test. 
 
Scheme 1. Exposure design  
 
Figure 1. Oral administration of anthocyanin (200 mg/kg) once a day during 7 
days prevents the impairment of memory induced by icv-STZ (3 mg/kg) in adult 
rats. (A) Number of crossing, (B) number of rearing and (C) latency of training 
(s) were was reported as means ± S.E.M and analyzed by one or two-way 
ANOVA, followed by Tukey test. (D) Latency of test (s) was reported as median 
± interquartile range with 8-10 rats for group. *Denotes P<0.05 as compared to 
the others groups, # Denotes P<0.05 as compared with icv-STZ group by 
Scheirer-Ray-Hare test (nonparametric two-way ANOVA); H2 = 9,75; P< 0,01. 
 
Figure 2. Effects of anthocyanin (200mg/kg) treatment and icv-STZ (3mg/kg) 
injection on anxiety-like behavior in the elevated plus maze task: (A) number of 
entries in arms; (B) number of entries in open arm; (C) time in closed arms (s) 
and (D) percentage of time in open arm. Data are reported as means ± S.E.M. 
with 8-10 rats for group. *Denotes P<0.05 as compared to the control (CTRL) 
group, ANOVA (two-way) followed by Tukey test. 
 
Figure 3. Anthocyanin (100µM) reduced the specific [3H] flunitrazepam binding 
to benzodiazepinic site of GABAA receptors. Data are reported as means ± 
S.E.M. *P<0.05 compared with the Diazepan (0.1 µM) and control groups; 
***P<0.01 compared with control and ANT groups. ANOVA (one-way) followed 
by Tukey test. 
 
Figure 4. AChE activity (A) in supernatant fraction and (B) synaptosomes 
fraction of hippocampus and cerebral cortex in CTRL, ANT, STZ and STZ+ANT 
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groups. Data are reported as means ± S.E.M. with 8-10 rats for group.  *P<0.05 
compared with the others groups; ANOVA (two-way) followed by Tukey test. 
 
Figure 5. Relative gene expression pattern of AChE (A) in hippocampus and 
(B) cerebral cortex in CTRL, ANT, STZ and STZ+ANT groups. Data are  
reported as means ± S.E.M. with 4 rats for group. *P<0.05 compared with the 
others groups; ANOVA (two-way) followed by Tukey test. No significative 
changes were observed between groups. 
 
Figure 6. Na+,K+-ATPase (A) and Ca+-ATPase (B) activity in hippocampus and 
cerebral cortex in CTRL, ANT, STZ and STZ+ANT groups. Data are reported as 
means ± S.E.M. with 8-10 rats for group. *P<0.05 compared with the others 
groups; ANOVA (two-way) followed by Tukey test. 
 
Figure 7. Effects of anthocyanin and icv-STZ administration on NOx levels in 
hippocampus and cerebral cortex of rats. Data are reported as means ± S.E.M. 
with 8-10 rats for group. *P<0.05 compared with the others groups; ANOVA 
(two-way) followed by Tukey test. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
29 
 
References 
Andres-Lacueva C, Shukitt-Hale B, Galli RL, Jauregui O, Lamuela-Raventos RM, 
Joseph JA. Anthocyanins in aged blueberry-fed rats are found centrally and may 
enhance memory. Nutritional neuroscience. 2005;8:111-20. 
Awasthi H, Tota S, Hanif K, Nath C, Shukla R. Protective effect of curcumin against 
intracerebral streptozotocin induced impairment in memory and cerebral blood flow. 
Life Sci. 2010;86:87-94. 
Barros D, Amaral OB, Izquierdo I, Geracitano L, do Carmo Bassols Raseira M, 
Henriques AT, et al. Behavioral and genoprotective effects of Vaccinium berries intake 
in mice. Pharmacology, biochemistry, and behavior. 2006;84:229-34. 
Belzung C, Griebel G. Measuring normal and pathological anxiety-like behaviour in 
mice: a review. Behav Brain Res. 2001;125:141-9. 
Benarroch EE. Na+, K+-ATPase: functions in the nervous system and involvement 
in neurologic disease. Neurology. 2011;76:287-93. 
Berlese DB, Sauzem PD, Carati MC, Guerra GP, Stiegemeier JA, Mello CF, et al. 
Time-dependent modulation of inhibitory avoidance memory by spermidine in rats. 
Neurobiol Learn Mem. 2005;83:48-53. 
Berrocal M, Marcos D, Sepulveda MR, Perez M, Avila J, Mata AM. Altered Ca2+ 
dependence of synaptosomal plasma membrane Ca2+-ATPase in human brain 
affected by Alzheimer's disease. The FASEB journal : official publication of the 
Federation of American Societies for Experimental Biology. 2009;23:1826-34. 
Blokland A. Acetylcholine: a neurotransmitter for learning and memory? Brain Res 
Brain Res Rev. 1995;21:285-300. 
Blokland A, Jolles J. Spatial learning deficit and reduced hippocampal ChAT activity 
in rats after an ICV injection of streptozotocin. Pharmacology, biochemistry, and 
behavior. 1993;44:491-4. 
Boldyrev A, Bulygina E, Carpenter D, Schoner W. Glutamate receptors 
communicate with Na+/K+-ATPase in rat cerebellum granule cells: demonstration of 
differences in the action of several metabotropic and ionotropic glutamate agonists on 
intracellular reactive oxygen species and the sodium pump. J Mol Neurosci. 
2003;21:213-22. 
Boldyrev A, Bulygina E, Gerassimova O, Lyapina L, Schoner W. Functional 
relationship between Na/K-ATPase and NMDA-receptors in rat cerebellum granule 
cells. Biochemistry (Mosc). 2004;69:429-34. 
Boldyrev AA, Bulygina ER. Na/K-ATPase and oxidative stress. Ann N Y Acad Sci. 
1997;834:666-8. 
Boldyrev AA, Bulygina ER, Kramarenko GG, Vanin AF. Effect of nitroso compounds 
on Na/K-ATPase. Biochim Biophys Acta. 1997;1321:243-51. 
Bradford MM. A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 
1976;72:248-54. 
Carvalho FB, Mello CF, Marisco PC, Tonello R, Girardi BA, Ferreira J, et al. 
Spermidine decreases Na(+),K(+)-ATPase activity through NMDA receptor and protein 
kinase G activation in the hippocampus of rats. Eur J Pharmacol. 2012;684:79-86. 
Casteels R, Wuytack F, Raeymaekers L, Himpens B. Ca(2+)-transport ATPases 
and Ca(2+)-compartments in smooth muscle cells. Zeitschrift fur Kardiologie. 1991;80 
Suppl 7:65-8. 
da Silva RS, Richetti SK, da Silveira VG, Battastini AM, Bogo MR, Lara DR, et al. 
Maternal caffeine intake affects acetylcholinesterase in hippocampus of neonate rats. 
International journal of developmental neuroscience : the official journal of the 
International Society for Developmental Neuroscience. 2008;26:339-43. 
de la Monte SM, Tong M, Lester-Coll N, Plater M, Jr., Wands JR. Therapeutic 
rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's 
disease. Journal of Alzheimer's disease : JAD. 2006;10:89-109. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
30 
 
Della-Pace ID, Rambo LM, Ribeiro LR, Saraiva AL, de Oliveira SM, Silva CR, et al. 
Triterpene 3beta, 6beta, 16beta trihidroxilup-20(29)-ene protects against excitability 
and oxidative damage induced by pentylenetetrazol: the role of Na(+),K(+)-ATPase 
activity. Neuropharmacology. 2013;67:455-64. 
dos Reis EA, de Oliveira LS, Lamers ML, Netto CA, Wyse AT. Arginine 
administration inhibits hippocampal Na(+),K(+)-ATPase activity and impairs retention of 
an inhibitory avoidance task in rats. Brain Res. 2002;951:151-7. 
East SJ, Garthwaite J. NMDA receptor activation in rat hippocampus induces cyclic 
GMP formation through the L-arginine-nitric oxide pathway. Neurosci Lett. 
1991;123:17-9. 
Ellman GL, Courtney KD, Andres V, Jr., Feather-Stone RM. A new and rapid 
colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 
1961;7:88-95. 
Faria A, Pestana D, Azevedo J, Martel F, de Freitas V, Azevedo I, et al. Absorption 
of anthocyanins through intestinal epithelial cells - Putative involvement of GLUT2. 
Molecular nutrition & food research. 2009a;53:1430-7. 
Faria A, Pestana D, Monteiro R, Teixeira D, Azevedo J, Freitas V. Bioavailability of 
anthocyanin-pyruvic acid adducts in rat. In International conference on polyphenols and 
health 2009b:170–1. 
Fedele E, Ansaldo MA, Varnier G, Raiteri M. Benzodiazepine-sensitive GABA(A) 
receptors limit the activity of the NMDA/NO/cyclic GMP pathway: a microdialysis study 
in the cerebellum of freely moving rats. J Neurochem. 2000;75:782-7. 
Fiske CH, Subbarow Y. The Nature of the "Inorganic Phosphate" in Voluntary 
Muscle. Science. 1927;65:401-3. 
Frussa-Filho R, Barbosa-Junior H, Silva RH, Da Cunha C, Mello CF. Naltrexone 
potentiates the anxiolytic effects of chlordiazepoxide in rats exposed to novel 
environments. Psychopharmacology (Berl). 1999;147:168-73. 
Fujisawa H, Kajikawa K, Ohi Y, Hashimoto Y, Yoshida H. Movement of radioactive 
calcium in brain slices and influences on it of protoveratrine, ouabain, potassium 
chloride and cocaine. Jpn J Pharmacol. 1965;15:327-34. 
Gether U, Andersen PH, Larsson OM, Schousboe A. Neurotransmitter transporters: 
molecular function of important drug targets. Trends Pharmacol Sci. 2006;27:375-83. 
Gouaux E. Review. The molecular logic of sodium-coupled neurotransmitter 
transporters. Philosophical transactions of the Royal Society of London Series B, 
Biological sciences. 2009;364:149-54. 
Gutierres JM, Carvalho FB, Rosa MM, Schmatz R, Rodrigues M, Vieira JM, et al. 
Protective effect of α-Tocopherol on memory deficits and Na+,K+-ATPase and 
acetylcholinesterase activities in rats with diet-induced hypercholesterolemia. 
Biomedicine & Aging Pathology. 2012a;2:73-80. 
Gutierres JM, Carvalho FB, Schetinger MR, Rodrigues MV, Schmatz R, Pimentel 
VC, et al. Protective effects of anthocyanins on the ectonucleotidase activity in the 
impairment of memory induced by scopolamine in adult rats. Life Sci. 2012b;91:1221-8. 
Gutierres JM, Kaizer RR, Schmatz R, Mazzanti CM, Vieira JM, Rodrigues MV, et al. 
alpha-Tocopherol regulates ectonucleotidase activities in synaptosomes from rats fed a 
high-fat diet. Cell Biochem Funct. 2012c. 
Harborne JB, Williams CA. Anthocyanins and other flavonoids. Natural product 
reports. 2001;18:310-33. 
Hoyer S. Causes and consequences of disturbances of cerebral glucose 
metabolism in sporadic Alzheimer disease: therapeutic implications. Adv Exp Med Biol. 
2004a;541:135-52. 
Hoyer S. Glucose metabolism and insulin receptor signal transduction in Alzheimer 
disease. Eur J Pharmacol. 2004b;490:115-25. 
Huang H, Nagaraja RY, Garside ML, Akemann W, Knopfel T, Empson RM. 
Contribution of plasma membrane Ca ATPase to cerebellar synapse function. World 
journal of biological chemistry. 2010;1:95-102. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
31 
 
Jimenez T, Sanchez G, Wertheimer E, Blanco G. Activity of the Na,K-ATPase 
alpha4 isoform is important for membrane potential, intracellular Ca2+, and pH to 
maintain motility in rat spermatozoa. Reproduction. 2010;139:835-45. 
Jorgensen PL, Hakansson KO, Karlish SJ. Structure and mechanism of Na,K-
ATPase: functional sites and their interactions. Annu Rev Physiol. 2003;65:817-49. 
Juranic Z, Zizak Z. Biological activities of berries: from antioxidant capacity to anti-
cancer effects. Biofactors. 2005;23:207-11. 
Kahkonen MP, Heinonen M. Antioxidant activity of anthocyanins and their aglycons. 
Journal of agricultural and food chemistry. 2003;51:628-33. 
Kahkonen MP, Hopia AI, Heinonen M. Berry phenolics and their antioxidant activity. 
Journal of agricultural and food chemistry. 2001;49:4076-82. 
Kalt W, Blumberg JB, McDonald JE, Vinqvist-Tymchuk MR, Fillmore SA, Graf BA, et 
al. Identification of anthocyanins in the liver, eye, and brain of blueberry-fed pigs. 
Journal of agricultural and food chemistry. 2008;56:705-12. 
Kaplan JH. Biochemistry of Na,K-ATPase. Annu Rev Biochem. 2002;71:511-35. 
Ke Z, Liu Y, Wang X, Fan Z, Chen G, Xu M, et al. Cyanidin-3-glucoside ameliorates 
ethanol neurotoxicity in the developing brain. Journal of neuroscience research. 
2011;89:1676-84. 
Kim HG, Ju MS, Shim JS, Kim MC, Lee SH, Huh Y, et al. Mulberry fruit protects 
dopaminergic neurons in toxin-induced Parkinson's disease models. The British journal 
of nutrition. 2010;104:8-16. 
Krikorian R, Shidler MD, Nash TA, Kalt W, Vinqvist-Tymchuk MR, Shukitt-Hale B, et 
al. Blueberry supplementation improves memory in older adults. Journal of agricultural 
and food chemistry. 2010;58:3996-4000. 
Lannert H, Hoyer S. Intracerebroventricular administration of streptozotocin causes 
long-term diminutions in learning and memory abilities and in cerebral energy 
metabolism in adult rats. Behav Neurosci. 1998;112:1199-208. 
Lees GJ, Lehmann A, Sandberg M, Hamberger A. The neurotoxicity of ouabain, a 
sodium-potassium ATPase inhibitor, in the rat hippocampus. Neurosci Lett. 
1990;120:159-62. 
Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM. 
Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic 
Alzheimer's disease. Journal of Alzheimer's disease : JAD. 2006;9:13-33. 
Li S, Stys PK. Na(+)-K(+)-ATPase inhibition and depolarization induce glutamate 
release via reverse Na(+)-dependent transport in spinal cord white matter. 
Neuroscience. 2001;107:675-83. 
Lingrel JB, Williams MT, Vorhees CV, Moseley AE. Na,K-ATPase and the role of 
alpha isoforms in behavior. J Bioenerg Biomembr. 2007;39:385-9. 
Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, et al. A redox-based 
mechanism for the neuroprotective and neurodestructive effects of nitric oxide and 
related nitroso-compounds. Nature. 1993;364:626-32. 
Lipton SA, Singel DJ, Stamler JS. Nitric oxide in the central nervous system. 
Progress in brain research. 1994;103:359-64. 
Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources 
and bioavailability. The American journal of clinical nutrition. 2004;79:727-47. 
Mata AM, Berrocal M, Sepulveda MR. Impairment of the activity of the plasma 
membrane Ca(2)(+)-ATPase in Alzheimer's disease. Biochem Soc Trans. 2011;39:819-
22. 
Min J, Yu SW, Baek SH, Nair KM, Bae ON, Bhatt A, et al. Neuroprotective effect of 
cyanidin-3-O-glucoside anthocyanin in mice with focal cerebral ischemia. Neurosci Lett. 
2011;500:157-61. 
Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for 
simultaneous detection of nitrate and nitrite. Nitric Oxide. 2001;5:62-71. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
32 
 
Missiaen L, Callewaert G, Parys JB, Wuytack F, Raeymaekers L, Droogmans G, et 
al. [Intracellular calcium: physiology and physiopathology]. Verhandelingen - 
Koninklijke Academie voor Geneeskunde van Belgie. 2000a;62:471-99. 
Missiaen L, Robberecht W, van den Bosch L, Callewaert G, Parys JB, Wuytack F, et 
al. Abnormal intracellular ca(2+)homeostasis and disease. Cell calcium. 2000b;28:1-
21. 
Moseley AE, Williams MT, Schaefer TL, Bohanan CS, Neumann JC, Behbehani 
MM, et al. Deficiency in Na,K-ATPase alpha isoform genes alters spatial learning, 
motor activity, and anxiety in mice. J Neurosci. 2007;27:616-26. 
Nagy A, Delgado-Escueta AV. Rapid preparation of synaptosomes from mammalian 
brain using nontoxic isoosmotic gradient material (Percoll). J Neurochem. 
1984;43:1114-23. 
Paleari L, Grozio A, Cesario A, Russo P. The cholinergic system and cancer. 
Seminars in cancer biology. 2008;18:211-7. 
Panayiotidis MI, Franco R, Bortner CD, Cidlowski JA. Ouabain-induced 
perturbations in intracellular ionic homeostasis regulate death receptor-mediated 
apoptosis. Apoptosis : an international journal on programmed cell death. 2010;15:834-
49. 
Passamonti S, Vrhovsek U, Vanzo A, Mattivi F. Fast access of some grape 
pigments to the brain. Journal of agricultural and food chemistry. 2005;53:7029-34. 
Paula-Lima AC, De Felice FG, Brito-Moreira J, Ferreira ST. Activation of GABA(A) 
receptors by taurine and muscimol blocks the neurotoxicity of beta-amyloid in rat 
hippocampal and cortical neurons. Neuropharmacology. 2005;49:1140-8. 
Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Academic Press, 
San Diego. 1986. 
Pergola C, Rossi A, Dugo P, Cuzzocrea S, Sautebin L. Inhibition of nitric oxide 
biosynthesis by anthocyanin fraction of blackberry extract. Nitric Oxide. 2006;15:30-9. 
Pinton S, da Rocha JT, Gai BM, Nogueira CW. Sporadic dementia of Alzheimer's 
type induced by streptozotocin promotes anxiogenic behavior in mice. Behav Brain 
Res. 2011;223:1-6. 
Pinton S, da Rocha JT, Zeni G, Nogueira CW. Organoselenium improves memory 
decline in mice: involvement of acetylcholinesterase activity. Neurosci Lett. 
2010;472:56-60. 
Prast H, Philippu A. Nitric oxide as modulator of neuronal function. Prog Neurobiol. 
2001;64:51-68. 
Raeymaekers L, Wuytack F. [The Ca(2+)-transport ATPases of smooth muscle]. 
Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie. 1991;53:605-
28. 
Rocha JB, Emanuelli T, Pereira ME. Effects of early undernutrition on kinetic 
parameters of brain acetylcholinesterase from adult rats. Acta neurobiologiae 
experimentalis. 1993;53:431-7. 
Rohn TT, Hinds TR, Vincenzi FF. Ion transport ATPases as targets for free radical 
damage. Protection by an aminosteroid of the Ca2+ pump ATPase and Na+/K+ pump 
ATPase of human red blood cell membranes. Biochem Pharmacol. 1993;46:525-34. 
Rubin MA, Albach CA, Berlese DB, Bonacorso HG, Bittencourt SR, Queiroz CM, et 
al. Anxiolytic-like effects of 4-phenyl-2-trichloromethyl-3H-1, 5-benzodiazepine 
hydrogen sulfate in mice. Braz J Med Biol Res. 2000a;33:1069-73. 
Rubin MA, Boemo RL, Jurach A, Rojas DB, Zanolla GR, Obregon AD, et al. 
Intrahippocampal spermidine administration improves inhibitory avoidance 
performance in rats. Behav Pharmacol. 2000b;11:57-61. 
Ruknudin AM, Lakatta EG. The regulation of the Na/Ca exchanger and 
plasmalemmal Ca2+ ATPase by other proteins. Ann N Y Acad Sci. 2007;1099:86-102. 
Rutkowski R, Pancewicz SA, Rutkowski K, Rutkowska J. [Reactive oxygen and 
nitrogen species in inflammatory process]. Polski merkuriusz lekarski : organ Polskiego 
Towarzystwa Lekarskiego. 2007;23:131-6. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
33 
 
Saija A, Princi P, D'Amico N, De Pasquale R, Costa G. Effect of Vaccinium myrtillus 
anthocyanins on triiodothyronine transport into brain in the rat. Pharmacol Res. 
1990;22 Suppl 3:59-60. 
Sattler R, Xiong Z, Lu WY, Hafner M, MacDonald JF, Tymianski M. Specific coupling 
of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science. 
1999;284:1845-8. 
Sharma M, Gupta YK. Intracerebroventricular injection of streptozotocin in rats 
produces both oxidative stress in the brain and cognitive impairment. Life Sci. 
2001;68:1021-9. 
Shih PH, Chan YC, Liao JW, Wang MF, Yen GC. Antioxidant and cognitive 
promotion effects of anthocyanin-rich mulberry (Morus atropurpurea L.) on 
senescence-accelerated mice and prevention of Alzheimer's disease. The Journal of 
nutritional biochemistry. 2010;21:598-605. 
Shin WH, Park SJ, Kim EJ. Protective effect of anthocyanins in middle cerebral 
artery occlusion and reperfusion model of cerebral ischemia in rats. Life sciences. 
2006;79:130-7. 
Shukitt-Hale B, Cheng V, Joseph JA. Effects of blackberries on motor and cognitive 
function in aged rats. Nutritional neuroscience. 2009;12:135-40. 
Takeguchi CA, Honegger UE, Holland WW, Titus EO. Evidence for subclasses of 
SH groups in (Na++K+)-ATPase. Life Sci. 1976;19:797-805. 
Talavera S, Felgines C, Texier O, Besson C, Gil-Izquierdo A, Lamaison JL, et al. 
Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and 
brain. Journal of agricultural and food chemistry. 2005;53:3902-8. 
Tiwari V, Kuhad A, Bishnoi M, Chopra K. Chronic treatment with tocotrienol, an 
isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive 
impairment and oxidative-nitrosative stress in rats. Pharmacology, biochemistry, and 
behavior. 2009;93:183-9. 
Tota S, Awasthi H, Kamat PK, Nath C, Hanif K. Protective effect of quercetin against 
intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of 
memory in mice. Behav Brain Res. 2010;209:73-9. 
Tota S, Kamat PK, Awasthi H, Singh N, Raghubir R, Nath C, et al. Candesartan 
improves memory decline in mice: involvement of AT1 receptors in memory deficit 
induced by intracerebral streptozotocin. Behav Brain Res. 2009;199:235-40. 
Tota S, Kamat PK, Saxena G, Hanif K, Najmi AK, Nath C. Central angiotensin 
converting enzyme facilitates memory impairment in intracerebroventricular 
streptozotocin treated rats. Behav Brain Res. 2012;226:317-30. 
Trevisan G, Maldaner G, Velloso NA, Sant'Anna Gda S, Ilha V, Velho Gewehr Cde 
C, et al. Antinociceptive effects of 14-membered cyclopeptide alkaloids. Journal of 
natural products. 2009;72:608-12. 
Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and 
antioxidants in normal physiological functions and human disease. The international 
journal of biochemistry & cell biology. 2007;39:44-84. 
Varadinova MG, Docheva-Drenska DI, Boyadjieva NI. Effects of anthocyanins on 
learning and memory of ovariectomized rats. Menopause. 2009;16:345-9. 
Veitch NC, Grayer RJ. Flavonoids and their glycosides, including anthocyanins. 
Natural product reports. 2011;28:1626-95. 
Wang Q, Xia M, Liu C, Guo H, Ye Q, Hu Y, et al. Cyanidin-3-O-beta-glucoside 
inhibits iNOS and COX-2 expression by inducing liver X receptor alpha activation in 
THP-1 macrophages. Life sciences. 2008;83:176-84. 
Williams CA, Grayer RJ. Anthocyanins and other flavonoids. Natural product 
reports. 2004;21:539-73. 
Williams CM, El Mohsen MA, Vauzour D, Rendeiro C, Butler LT, Ellis JA, et al. 
Blueberry-induced changes in spatial working memory correlate with changes in 
hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) 
levels. Free radical biology & medicine. 2008;45:295-305. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
34 
 
Wyse AT, Streck EL, Barros SV, Brusque AM, Zugno AI, Wajner M. Methylmalonate 
administration decreases Na+,K+-ATPase activity in cerebral cortex of rats. 
Neuroreport. 2000;11:2331-4. 
Yoshida K, Mori M, Kondo T. Blue flower color development by anthocyanins: from 
chemical structure to cell physiology. Natural product reports. 2009;26:884-915. 
Zhang L, Guo F, Su S, Guo H, Xiong C, Yin J, et al. Na(+) /K(+) -ATPase inhibition 
upregulates NMDA-evoked currents in rat hippocampal CA1 pyramidal neurons. 
Fundam Clin Pharmacol. 2011. 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
35 
 
Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
10
20
30
A
CTRL ANT STZ STZ+ANT
N
u
m
b
e
r 
o
f 
c
ro
s
s
in
g
0
2
4
6
8
10
C
CTRL ANT STZ STZ+ANT
L
a
te
n
c
y
 o
f 
tr
a
in
in
g
 (
S
)
0
5
10
15
20
25
B
CTRL ANT STZ STZ+ANT
N
u
m
b
e
r 
o
f 
re
a
ri
n
g
0
100
200
300
400
*
D
#
CTRL ANT STZ STZ+ANT
L
a
te
n
c
y
 (
s
)
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
36 
 
 
Figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
0
1
2
3
4
5
A
CTRL ANT STZ STZ+ANT
N
º 
E
n
tr
ie
s
 i
n
 A
rm
s
0
50
100
150
200
250
300
*
*
C
CTRL ANT STZ STZ+ANT
T
im
e
 i
n
 C
lo
s
e
d
 A
rm
 (
s
)
0.0
0.2
0.4
0.6
0.8
1.0
B
CTRL ANT STZ STZ+ANT
N
º 
E
n
tr
ie
s
 i
n
 O
p
e
n
 A
rm
s
0
5
10
15
20
*
D
CTRL ANT STZ STZ+ANT
 T
im
e
 i
n
 O
p
e
n
 A
rm
s
 (
s
)
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
37 
 
 
 
 
Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
CTRL 100 0.1
0
50
100
150
Diazepam (M)ANT (M)
***
*
%
 s
p
e
c
if
ic
 b
in
d
in
g
[3
H
]F
lu
n
it
ra
z
e
p
a
n
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
38 
 
 
Figure 4 
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Figure 5 
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Figure 6 
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Table 1. Structural identification of anthocyanins. 
 
 
 
Anthocyanins R1 R2    Formula  M.W 
 
Cyanidin 
 
OH 
 
H 
 
C15H11O6 
 
322,72 
Malvidin OCH3 H C16H13O6 336,74 
Delphinidin OH OH C15H11O7 338,72 
Petunidin OCH3 OH C16H13O7 352,74 
Malvidin OCH3 OCH3 C17H15O7 366,77 
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Table 2  
 
 
PCR primers 
design 
  
 
Proteins 
 
Primer sequences (50–30) 
Accession number 
           (mRNA) 
 
β-Actina 
 
F-TATGCCAACACAGTGCTGTCTGG  
R-TACTCCTGCTTCCTGATCCACAT 
 
ENSDART00000055194 
 
AChEa 
 
F-GACTGCCTTTATCTTAATGTG  
R-CGGCTGATGAGAGATTCATTG 
 
 
NP_571921 
 
 
a According to Silva et al., 2008 
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Table 3 
Groups Glucose levels (mmol/L) 
  
CTRL 109.36 ± 2.20 
ANT 102.66 ± 2.13 
STZ 110.44 ± 1.92 
STZ+ANT 106.77 ± 2.09 
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Table 4 
 
Group 
 
Flinch (mA) 
 
Jump (mA) 
 
Vocalization (mA) 
 
CTRL 
 
0.18 ± 0.01 
 
0.22 ± 0.02 
 
0.42 ± 0.01 
ANT 0.20 ± 0.01 0.23 ± 0.02 0.41 ± 0.02 
STZ 0.21 ± 0.01 0.21 ± 0.02 0.43 ± 0.01 
STZ+ANT  0.18 ± 0.01 0.24 ± 0.01 0.44 ± 0.01 
Statistical 
Analysis 
F(3.30)= 1.33; 
p>0.05 
F(3.30)= 1.66; 
p>0.05 
F(3.30)= 1.76; 
p>0.05 
Data are means ± SEM for 6-10 animals in each group.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
